3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
18
Gastrointestinal Stromal Tumors
10
Neoplasms
5
Neoplasm Metastasis
4
Multiple Myeloma
4
Kidney Neoplasms
4
Urologic Neoplasms
2
Thyroid Neoplasms
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Meningioma
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Kidney Diseases
2
Gastrointestinal Neoplasms
2
Carcinoma, Hepatocellular
2
Carcinoma
2
Adenoma, Islet Cell
2
Uveal Melanoma
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thymoma
1
Stomach Neoplasms
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Rectal Neoplasms
1
Primary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Interventions
Azacitidine
26
venetoclax
20
Cyclophosphamide
17
fludarabine phosphate
14
Whole-Body Irradiation
13
Biopsy
13
fludarabine
12
Specimen Handling
12
Tacrolimus
11
Mycophenolic Acid
11
Decitabine
10
Stem Cell Transplantation
9
Peripheral Blood Stem Cell Transplantation
9
Injections
8
Cytarabine
8
Busulfan
8
decitabine and cedazuridine drug combination
7
Melphalan
7
X-Rays
5
Hematopoietic Stem Cell Transplantation
5
Cyclosporine
5
Sirolimus
4
ruxolitinib
3
olutasidenib
3
enasidenib
3
cedazuridine
3
Magnetic Resonance Spectroscopy
3
Idarubicin
3
Granulocyte Colony-Stimulating Factor
3
Filgrastim
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelomonocytic, Chronic
×
Sunitinib
×
1 year
×
Clear all
No trials found.